BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 9547521)

  • 1. On the relationship between the substitution pattern of thiobenzanilides and their antimycobacterial activity.
    Kunes J; Balsánek V; Pour M; Waisser K; Kaustová J
    Farmaco; 2002 Sep; 57(9):777-82. PubMed ID: 12385530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
    Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
    Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
    Bergmann KE; Cynamon MH; Welch JT
    J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
    Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
    Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
    Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
    Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of antimycobacterial drugs.
    David HL; Laszlo A; Rastogi N
    Acta Leprol; 1989; 7 Suppl 1():189-94. PubMed ID: 2503988
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimycobacterial activity of 3'- and 4'-fluorothiobenzanilides.
    Waisser K; Kunes J; Odlerová Z; Roman M; Kubicová L; Horák V
    Pharmazie; 1998 Mar; 53(3):193-5. PubMed ID: 9547521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterocyclic isosters of antimycobacterial salicylanilides.
    Matyk J; Waisser K; Drazková K; Kunes J; Klimesová V; Palát K; Kaustová J
    Farmaco; 2005 May; 60(5):399-408. PubMed ID: 15910812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity of 2-hydroxythiobenzanilides and related compounds.
    Kubicová L; Sustr M; Pravda M; Waisser K
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S57-9. PubMed ID: 15141980
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.